Ceramide Metabolism and Photoreceptor Homeostasis

神经酰胺代谢和感光器稳态

基本信息

  • 批准号:
    7386649
  • 负责人:
  • 金额:
    $ 34.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Sphingolipids are integral components of all eukaryotic cell membranes; many of them like ceramide, sphingosine, sphingosine-1 -phosphate (S-1-P) are also bioactive lipids regulating cellular functions ranging from apoptosis to angiogenesis. Our long-term goal is to comprehensively understand functions of enzymes that control normal sphingolipid metabolism and their integration into other pathways involved in cell growth, differentiation and signaling. To address our goal, we study enzymes of sphingolipid biosynthesis using Drosophila as a model system. This proposal is based on the observation that sphingolipid metabolism plays an important role in survival of photoreceptors. Our findings show that decreasing ceramide levels by genetic modulation of the sphingolipid biosynthetic pathway suppresses retinal degeneration in a set of phototransduction mutants. Recent studies in human patients show that mutations in enzymes of ceramide metabolism cause Retinitis Pigmentosa and Hereditary Sensory Neuropathy. Based on these findings, the focus of this project is to understand how ceramide metabolism contributes to maintenance of photoreceptor homeostasis and other cellular functions. We will elucidate in vivo functions of three enzymes that decrease ceramide levels - ceramidase that converts ceramide to sphingosine, ceramide kinase that converts ceramide to ceramide-1-phosphate and sphingosine kinase that converts sphingosine to S-1-P. While ceramide and sphingosine are pro-death, S-1-P is pro-growth. The relative level of these antagonistic metabolites, regulated by the biosynthetic enzymes, determines whether a cell survives or dies. The specific aims of the project are (1) study components downstream of ceramidase in suppression of retinal degeneration and elucidate ceramidase function using a mutant (2) generate ceramide kinase mutant and transgenic flies to study its functions (3) generate and analyze mutant and transgenic flies to define the role of sphingosine kinase in regulating levels of sphingolipid metabolites.
说明(申请人提供):鞘氨醇是所有真核细胞膜不可或缺的成分;其中许多如神经酰胺、鞘氨醇、1-磷酸鞘氨醇(S-1-P)也是生物活性脂类,调节从细胞凋亡到血管生成的各种细胞功能。我们的长期目标是全面了解控制正常鞘磷脂代谢的酶的功能,以及它们与参与细胞生长、分化和信号传递的其他途径的整合。为了达到我们的目标,我们以果蝇为模型系统,研究了鞘脂生物合成的酶。 这一建议是基于对鞘磷脂代谢在光感受器存活中发挥重要作用的观察得出的。我们的发现表明,通过神经鞘脂脂生物合成途径的遗传调节来降低神经酰胺水平可以抑制一组光转导突变体中的视网膜退化。最近在人类患者中的研究表明,神经酰胺代谢酶的突变会导致视网膜色素变性和遗传性感觉神经病。基于这些发现,本项目的重点是了解神经酰胺代谢如何有助于维持光感受器稳态和其他细胞功能。我们将阐明三种降低神经酰胺水平的酶在体内的作用--将神经酰胺转化为鞘氨醇的神经酰胺酶,将神经酰胺转化为神经酰胺-1-磷酸的神经酰胺酶,以及将鞘氨醇转化为S-1-P的鞘氨醇激酶。神经酰胺和鞘氨醇具有促死亡作用,而S-1-P具有促生长作用。由生物合成酶调节的这些拮抗代谢物的相对水平决定了细胞的生存或死亡。该项目的具体目标是(1)研究神经酰胺酶下游的成分在抑制视网膜变性中的作用,并利用突变体阐明神经酰胺酶的功能(2)产生神经酰胺酶突变体和转基因果蝇以研究其功能(3)产生并分析突变体和转基因果蝇以确定鞘氨醇激酶在调节鞘磷脂代谢产物水平中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

USHA R ACHARYA其他文献

USHA R ACHARYA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('USHA R ACHARYA', 18)}}的其他基金

Adaptation to ceramide involves AKT/FOXO regulated novel triglyceride lipases
对神经酰胺的适应涉及 AKT/FOXO 调节的新型甘油三酯脂肪酶
  • 批准号:
    9118308
  • 财政年份:
    2015
  • 资助金额:
    $ 34.79万
  • 项目类别:
Adaptation to ceramide involves AKT/FOXO regulated novel triglyceride lipases
对神经酰胺的适应涉及 AKT/FOXO 调节的新型甘油三酯脂肪酶
  • 批准号:
    9257441
  • 财政年份:
    2015
  • 资助金额:
    $ 34.79万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    7045994
  • 财政年份:
    2005
  • 资助金额:
    $ 34.79万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    7599588
  • 财政年份:
    2005
  • 资助金额:
    $ 34.79万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    8107800
  • 财政年份:
    2005
  • 资助金额:
    $ 34.79万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    8446421
  • 财政年份:
    2005
  • 资助金额:
    $ 34.79万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    8245706
  • 财政年份:
    2005
  • 资助金额:
    $ 34.79万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    6907795
  • 财政年份:
    2005
  • 资助金额:
    $ 34.79万
  • 项目类别:
Ceramide Metabolism and Photoreceptor Homeostasis
神经酰胺代谢和感光器稳态
  • 批准号:
    7210558
  • 财政年份:
    2005
  • 资助金额:
    $ 34.79万
  • 项目类别:
MOD OF SPHINGOLIPID BIOSYNTHETIC PATHWAY RESCUES: PHOTORECEPTOR DEGENERATION
鞘脂生物合成途径拯救的模式:光感受器变性
  • 批准号:
    6977005
  • 财政年份:
    2003
  • 资助金额:
    $ 34.79万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 34.79万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.79万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 34.79万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.79万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 34.79万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.79万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 34.79万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 34.79万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 34.79万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 34.79万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了